KRT5 and ovarian carcinoma: Using the publically available Kaplan-Meir online plotter tool which incorporates gene expression data from 13 ovarian cancer sets including the TCGA dataset [31], high KRT5 expression was associated with reduced progression-free survival (PFS, HR 1.38; 95% CI 1.16–1.64, P < 0.0001, Figure 3A) and overall survival (OS, HR 1.28 95%; CI 1.05–1.56, P = 0.013, Figure 3B).